The largest database of trusted experimental protocols

Maglumi 4000

Manufactured by Abbott

The MAGLUMI 4000 is an automated chemiluminescence immunoassay (CLIA) analyzer designed for in-vitro diagnostic testing. It is capable of performing a wide range of immunoassay tests, including tests for hormones, infectious diseases, and other clinical biomarkers. The MAGLUMI 4000 is equipped with advanced features such as high-throughput processing, precise sample handling, and reliable results reporting.

Automatically generated - may contain errors

2 protocols using maglumi 4000

1

Comprehensive metabolic and hormonal assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients underwent a 75 g OGTT and anthropometric measurements. All parameters were measured as previously described [5 (link)].
Fasting blood samples were obtained between the first and fifth day of the menstrual period/withdrawal bleeding. Prolactin, T, FT, and thyroid-stimulating hormone (TSH) were assessed by chemiluminescence immunometric assay (Beckman Unicel DxI 800; Snibe MAGLUMI 4000; Abbott Immulite 2000 analyzer). 17-α-Hydroxyprogesterone was measured using the enzyme-linked immunosorbent assay (ELISA). Plasma glucose was measured using the glucose oxidase method (Hitachi 7600 autoanalyzer). Plasma insulin was measured using a chemiluminescence immunometric assay (Roche e601 analyzer). Total cholesterol (CHOL), TG, HDL-c, and low-density lipoprotein cholesterol (LDL-c) were measured using the enzymatic colorimetric method (Hitachi 7600 autoanalyzer). Indices were calculated based on the following formulas.

  Body mass index (BMI) = weight (kg)/height2 (m)

  LAP = (WC (cm)–58) × TG (mmol/L) [9 (link)].

  CVAI = –187.32 + 1.71 × age + 4.23 × BMI + 1.12 × WC (cm) + 39.76 × log10[TG (mmol/L) ] – 11.66 × HDL (mmol/L) [14 (link)].

  VAI = [WC (cm)/[36.58 + (1.89 × BMI)]] × [TG (mmol/L)/0.81] × [1.52/HDL-C (mmol/L)] [15 (link)].

  WTI = WC (cm) × TG (mmol/L) [15 (link)].

  TyG = Ln (fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2) [17 (link)].

+ Open protocol
+ Expand
2

PCOS Patient Evaluation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the recruited patients underwent 75-g OGTT and anthropometric measurements. All parameters were measured, as previously described [7 (link), 22 (link)].
Fasting blood samples were obtained from PCOS patients between the first and fifth day of menstrual period/withdrawal bleeding. Prolactin and total testosterone (TT) were assessed by chemiluminescence immunometric assay (Beckman Unicel DxI 800). Free testosterone (FT) and thyroid-stimulating hormone were also measured using chemiluminescence immunometric assay (Snibe MAGLUMI 4000; Abbott Immulite 2000 analyzer). 17α-hydroxyprogesterone was measured using the ELISA method. Plasma glucose was measured using glucose oxidase method (Hitachi 7600 autoanalyzer). Plasma insulin was measured using chemiluminescence immunometric assay (Roche e601 analyzer). Total cholesterol (CHOL), triglycerides (TG), high-density lipoprotein cholesterol (HDL-c), and low-density lipoprotein cholesterol (LDL-c) were measured using enzymatic colorimetric method (Hitachi 7600 autoanalyzer).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!